3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Muscle Invasive Bladder Cancer (MIBC)
1
Limited Stage Small Cell Lung Cancer
1
Helicobacter Infections
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Adenomatous Polyposis Coli
1
Interventions
Fluorouracil
13
Cisplatin
7
Radiotherapy
6
Specimen Handling
5
Mitomycin
5
Capecitabine
5
pembrolizumab
4
dehydroftorafur
4
Radiation
4
Drug Therapy
4
Cetuximab
4
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
aldesleukin
2
VGX-3100
2
Platinum
2
Mitozytrex
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
1,2-diaminocyclohexaneplatinum II citrate
2
toripalimab
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
spartalizumab
1
rocakinogene sifuplasmid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anus Neoplasms
×
Probiotics
×
Clear all
NCT03870607
2023-01-17
BISQUIT
AC Camargo Cancer Center
Phase 2
Unknown
75 enrolled